# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Hippocrates (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC005-SYN
- Date: 2026-04-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Eleni Vasquez-Okafor, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Eight-week review. **S**

## History of present illness

Hippocrates has been to physical therapy every week and does his strength and balance exercises most days. The therapist visited his house three weeks ago; a second rail has been fitted on the stairs and night lights in the hall. He wears shoes with a back indoors. His knee pain on stairs is 3 of 10 with the gel most mornings, and he takes acetaminophen a few times a week. He had a cold two weeks ago that has cleared; he did not take the nighttime cold remedy again. He sleeps six to six and a half hours without a sleep aid. He has had no falls. He had a DXA scan this morning. **S**

| Element | Detail |
|---|---|
| Knee pain | 3 of 10 on stairs |
| DXA | Femoral neck T-score -1.7; total hip -1.4; spine -0.6 |
| FRAX | Major osteoporotic fracture 11 percent; hip 2.6 percent |
| Falls | None |
| Cold | Resolved |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Musculoskeletal | Positive | Knee ache on the hill; less on stairs |
| Respiratory | Negative | Cough gone |
| Integumentary | Negative | No rash where he applies the gel |
| Psychiatric | Negative | Mood good; sleeping without a sleep aid |

4 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day as needed for knee pain, no more than 3,000 mg in a day **S**
- Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once daily **S**
- Diclofenac 1% gel, 4 g rubbed into each painful knee up to four times a day **S**

## Allergies

- No known allergy **S**

## Objective

BP 134/72 mmHg; pulse 66 bpm; respirations 16/min; temperature 36.4 °C; oxygen saturation 97% on room air; weight 64.4 kg; BMI 22.8 kg/m². All vital signs are synthetic.

Femoral neck T-score (DXA, lower of the two hips): -1.7 (low); Total hip T-score (DXA): -1.4 (low); Lumbar spine T-score (DXA, L1 to L4): -0.6; FRAX 10-year major osteoporotic fracture risk: 11%; FRAX 10-year hip fracture risk: 2.6%; Knee pain (0 to 10): 3. All results are synthetic.

## Change since baseline

- Knee pain (0 to 10): 5 at baseline, 3 at this visit **S**

## Immunizations given today

- Pneumococcal conjugate vaccine (PCV20), single dose, one or more years after PPSV23 at 65 **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 134/72, pulse 66; weight 64.4 kg; height 168 cm, unchanged |
| Musculoskeletal | Both knees: crepitus, no effusion; quadriceps 4+ of 5 |
| Skin | No irritation over the knees |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Low bone mass** (M85.89). Femoral neck T-score -1.7 with FRAX risks of 11 percent (major) and 2.6 percent (hip), below the BHOF treatment thresholds of 20 and 3 percent; no vertebral fracture. Osteoporosis medicine is not indicated now. **S**
   - Continue vitamin D3 1,000 units daily and calcium from food.
   - Falls prevention as the main fracture prevention.
   - Repeat DXA and FRAX in two years, or sooner after any fracture.
2. **Primary osteoarthritis of both knees** (M17.0). Pain 3 of 10, within his goal; strength improving. **S**
   - Continue physical therapy to twelve weeks, then tai chi.
   - Diclofenac gel and acetaminophen as needed.
3. **Common cold** (J06.9). Resolved without a sedating remedy. **S**
   - No further treatment.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Knee pain (0 to 10) | Every visit | Completed today | 3 of 10 on stairs |
| Survey | Knee function (KOOS JR) | Every visit | Deferred | KOOS JR was not given at this visit: the form was left out of the visit packet. No harm is likely: the pain score and examination were recorded today and both show improvement. Corrective action: KOOS JR added to the visit template for his osteoarthritis visits and booked for the four-month review |
| Examination | Knee examination (range of movement, effusion, alignment, crepitus) | Every visit | Completed today | Crepitus, no effusion; quadriceps 4+ of 5 |
| Self-management | Exercise and self-management (strength and balance program, tai chi) | Every visit | Completed today | Weekly physical therapy and exercises most days |
| Self-management | Home safety check | Once, after a fall or near-fall | Completed today | Done three weeks ago: second stair rail and night lights fitted |
| Examination | Gait speed, Timed Up and Go, 30-second chair stand and four-stage balance test | At intake and after a strength and balance program | Due | After the twelve-week program, at the four-month review |
| Medication safety | Medication review (Beers 2023): no NSAID tablets, sedating antihistamines or other anticholinergic medicines; over-the-counter purchases | Every visit | Completed today | No NSAID tablets or sleep aids; the nighttime cold remedy was not taken again |
| Medication safety | Topical diclofenac: skin and use | Every visit | Completed today | Most mornings; no skin irritation |
| Laboratory | ALT with regular acetaminophen near 3 g a day | With regular use near 3 g a day | Not indicated | A few doses a week |
| Imaging | DXA and FRAX | At assessment, then every two years if untreated | Completed today | Femoral neck -1.7, total hip -1.4, spine -0.6; FRAX 11 and 2.6 percent; no vertebral fracture |
| Examination | Standing height | Yearly | Completed today | 168 cm, unchanged |
| Laboratory | 25-hydroxyvitamin D | At baseline, after repletion, then yearly | Up to date | Recheck at four months |
| Self-management | Vaccination review | Yearly | Completed today | PCV20 today; RSV and recombinant zoster at the wellness visit |
| Survey | What matters most (4Ms) | Every visit | Completed today | Walking to his teaching again, stopping twice on the hill |
| Survey | Mentation: mood, memory and sleep (4Ms) | Every visit | Completed today | Mood good; sleeping without a sleep aid |

## Goal progress

- Find out why he walks more slowly and nearly fell. Outcome by 2026-03-16: Knee osteoarthritis with reduced quadriceps strength and balance, and diphenhydramine at night; no neurologic, thyroid, B12 or blood pressure cause. **S**
- Walk into town and back for his teaching without stopping to rest, and climb his stairs safely. In progress; target 2026-09-28. **S**
- No medicine he does not need, and none on the Beers list. Outcome by 2026-04-27: Naproxen and diphenhydramine stopped; sleeping without a sleep aid; chose not to take a cold remedy with diphenhydramine. **S**
- Knee pain 3 of 10 or less on stairs. In progress; target 2026-06-29. **S**
- Bones and falls: vitamin D above 30 ng/mL and no falls. In progress; target 2027-03-02. **S**

## Guideline basis

- Age-Friendly Health Systems: the 4Ms (What Matters, Medication, Mentation, Mobility) (2026), Institute for Healthcare Improvement and The John A. Hartford Foundation
- American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023), American Geriatrics Society (J Am Geriatr Soc 2023;71(7):2052-2081)
- Updating STEADI for Primary Care: Recommendations From the American Geriatrics Society Workgroup (2025), American Geriatrics Society (J Am Geriatr Soc 2025;73(7):2019-2028)
- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019), American College of Rheumatology and Arthritis Foundation (Arthritis Care Res 2020;72(2):149-162)
- The clinician's guide to prevention and treatment of osteoporosis (2022), Bone Health and Osteoporosis Foundation (Osteoporos Int 2022;33(10):2049-2102)
- Osteoporosis in men: an Endocrine Society clinical practice guideline (2012), Endocrine Society (J Clin Endocrinol Metab 2012;97(6):1802-1822)
- CMID: Clinical Monitoring Intelligence Database, rheumatoid arthritis and osteoarthritis, and osteoporosis monographs (2026), Aether Forge

## Follow-up

- Annual wellness visit in six weeks. Four-month review with repeat gait, balance and strength measures, vitamin D and KOOS JR. **S**
- Next scheduled visit 2026-06-08: subsequent annual wellness visit. **S**
